Article by Jackie Vicksman

Population Council, a research-oriented NGO based in New York, has been pioneering research behind contraceptive multipurpose prevention technologies (cMPTs). Most recently, researchers have been developing a single product that combines contraception and Pre-Exposure Prophylaxis (PrEP) in order to reduce the risk of unintended pregnancy and HIV infection among young women in low and middle-income countries (LMICs). This product could contribute to both family planning initiatives and HIV prevention efforts. This project began in 2018 and is currently ongoing, yet researchers are unsure of when the product will be available to be tested and distributed. The team is particularly excited because one pill would make it easier for women to have control over their own reproduction and sexual health. The NGO is confident that this work will “confirm cMPT acceptability among young women and adolescent girls,” and will “explore the possibility of combining existing products into a single tablet and identify a clear pathway toward regulatory approval.”

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.